320056 VO Innovation and Leadership (2016S)
Labels
Course Dates (SS2016): 06 April - 13 May 2016
Je. Mi. 18.30 - 20.30 Uhr s.t. 06.04*, 13.04, 20.04, 27.04, 04.05, 11.05
Je. Fri. 17.00 - 19.00 Uhr s.t. 08.04*, 15.04, 22.04, 29.04, 06.05, 13.05
(* Mi. 06.04 18.30 - 20.00 Uhr s.t & Fri. 08.04 17.00 - 18.30 Uhr s.t.)Immer Seminarraum 2D313, UZA II
Je. Mi. 18.30 - 20.30 Uhr s.t. 06.04*, 13.04, 20.04, 27.04, 04.05, 11.05
Je. Fri. 17.00 - 19.00 Uhr s.t. 08.04*, 15.04, 22.04, 29.04, 06.05, 13.05
(* Mi. 06.04 18.30 - 20.00 Uhr s.t & Fri. 08.04 17.00 - 18.30 Uhr s.t.)Immer Seminarraum 2D313, UZA II
Details
Language: English
Examination dates
Lecturers
Classes (iCal) - next class is marked with N
- Wednesday 30.03. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 01.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 06.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 08.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 13.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 15.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 20.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 22.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 27.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 29.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 04.05. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 06.05. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Information
Aims, contents and method of the course
The pharmaceutical industry has produced impressive breakthrough medicines such as, insulin, first in class vaccines, antibiotics, retroviral and cancer therapies that have significantly impacted our society. Furthermore, rapid advances in technology, and infrastructure have resulted due to advancing R & D needs throughout the evolving process of designing new therapies. However, the industry has been criticized during the last decade for its lack of innovation. What exactly does ‘lack of innovation’ mean? Clearly the need to ‘be innovative’ is obvious. However, the process of finding novel solutions to problems, recognizing good ideas that meet needs and produce disruptive technologies or services to the market is extremely challenging.
Assessment and permitted materials
Minimum requirements and assessment criteria
This course will introduce the concept of innovation and disruptive technology as well as review exemplary innovators in health care?and other industries. Armed with this?knowledge, students will interactively experience the process of innovation in the context of a project related to pharmaceutical science that will provide a framework to explore the unique leadership competencies required to guide and shape creative teams and inspire the imagination needed to recognize a good idea and transform it into a useful or even disruptive technology. This course is in English and fulfills 1 ECTS.
Examination topics
Reading list
Association in the course directory
A 400
Last modified: Sa 02.04.2022 00:27